Results of two randomized trials evaluating adjuvant anthracycline-based chemotherapy in 1 146 patients with early breast cancer

By Arriagada Rodrigo   Spielmann Marc   Koscielny Serge   Le Chevalier Thierry   Delozier Thierry   Rémé-Saumon Monique   Ducourtieux Muriel   Tursz Thomas   Hill Catherine  

Acta Oncologica, Vol. 44, Iss. 5, 2005-07 ,pp. : 458-466

Informa Healthcare

Access to resources Recommend Favorite

Influence of circulating c-erbB-2 serum protein on response to adjuvant chemotherapy in node-positive breast cancer patients

By Fehm T.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 1, 1997-03 ,pp. : 87-95

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients - effect of adjuvant chemotherapy

By Poikonen P.   Saarto T.   Elomaa I.   Joensuu H.   Blomqvist C.  

European Journal of Cancer, Vol. 36, Iss. 1, 2000-01 ,pp. : 43-48

Elsevier

Access to resources Recommend Favorite

Quality of adjuvant CMF chemotherapy for node-positive primary breast cancer: a population-based study

By Schaapveld Michael   Vries Elisabeth   Graaf Winette   Otter Renée   Willemse Pax  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 10, 2004-10 ,pp. : 581-590

Springer Publishing Company

Access to resources Recommend Favorite

Clinical significance of pAkt and pErk1/2 expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy

By                

Oncology Letters, Vol. 9, Iss. 4, 2015-01 ,pp. : 1707-1714

Spandidos Publications

Access to resources Recommend Favorite